Gary Durack

Gary Durack is a biomedical engineer, inventor, and successful technology entrepreneur.

Gary began his career in 1979 at the Coulter Corporation, a world leader in IVD instrumentation. Until 2013 he served as CEO and CSO for iCyt Visionary Bioscience, a biomedical design engineering and product company which he founded in 1995. In 2009 iCyt was acquired by the Sony Corporation and renamed Sony Biotechnology.

In addition to his role at TEKMILL, Gary is an investor in technology startup companies and spends considerable time advising and encouraging their founders. He is an Adjunct Professor of Bioengineering at the University of Illinois and is affiliated with the Micro and Nano Technology Laboratory. He serves as a Business Mentor with the Chicago Innovation Mentor program, on the Institutional Review Board for Carle Foundation Hospital, and on several NIH SBIR study sections. Gary serves on the boards of TEKMILL, Aptimmune Biologics, PhotoniCare, and Exalt Diagnostics.